For research use only. Not for therapeutic Use.
Pterosin A is an orally active anti-diabetic agent. Pterosin A promotes glucose uptake, increases serum insulin, and improves hyperglycemia and glucose intolerance in diabetic mice. Pterosin A can be isolated from Pteridium aquilinum[1][2].
| Catalog Number | I040862 |
| CAS Number | 35910-16-8 |
| Synonyms | (2S)-6-(2-hydroxyethyl)-2-(hydroxymethyl)-2,5,7-trimethyl-3H-inden-1-one |
| Molecular Formula | C15H20O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C15H20O3/c1-9-6-11-7-15(3,8-17)14(18)13(11)10(2)12(9)4-5-16/h6,16-17H,4-5,7-8H2,1-3H3/t15-/m0/s1 |
| InChIKey | BDZJLPDYMKPKGC-HNNXBMFYSA-N |
| SMILES | CC1=CC2=C(C(=C1CCO)C)C(=O)C(C2)(C)CO |
| Reference | [1]. Hsu FL, et al. Antidiabetic effects of pterosin A, a small-molecular-weight natural product, on diabetic mouse models. Diabetes. 2013 Feb;62(2):628-38. [2]. Chen CY, et al. Chemical constituents analysis and antidiabetic activity validation of four fern species from Taiwan. Int J Mol Sci. 2015 Jan 22;16(2):2497-516. |
